IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Prevail Therapeutics Contra

CUSIP: 741CVR013 | 2 institutional holders

Quarters

Q1 2022Q1 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2022

Amalgamated Financial Corp.2,131
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Amalgamated Financial Corp.
2,131$00.0%N/AN/ANew York, NY2022-05-16